Autor/in Giagounidis, A Platzbecker, U 3 Götze, K 2 Haase, D 2 Letsch, A 2 Schlenk, R F 2 Shirneshan, K 2 Braulke, F 1 Bruns, I 1 Bug, G 1 Büsche, G 1 Czibere, A 1 Ganser, A 1 Jann, J-C 1 Luft, T 1 Mossner, M 1 Nolte, F 1 Nowak, D 1 Rieger, K 1 Schroeder, T 1 Schuler, E 1 Uharek, L 1 Wolschke, C 1 Zohren, F 1 alle zeigenListe einklappen
Prevalence, clonal dynamics and clinical impact of TP53 mutations in patients with myelodysplastic syndrome with isolated deletion (5q) treated with lenalidomide: results from a prospective multicenter study of the german MDS study group (GMDS) Mossner, M Jann, J-C Nowak, D Platzbecker, U Giagounidis, A Götze, K Letsch, A 2016 - Forschungsinformationssystem des UKE
Results of a multicenter prospective phase II trial investigating the safety and efficacy of lenalidomide in patients with myelodysplastic syndromes with isolated del(5q) (LE-MON 5) Schuler, E Giagounidis, A Haase, D Shirneshan, K Büsche, G Platzbecker, U Nolte, F 2016 - Forschungsinformationssystem des UKE
Azacitidine and donor lymphocyte infusions as first salvage therapy for relapse of AML or MDS after allogeneic stem cell transplantation Schroeder, T Czibere, A Platzbecker, U Bug, G Uharek, L Luft, T Giagounidis, A 2013 - Forschungsinformationssystem des UKE